Related references
Note: Only part of the references are listed.Efficacy of Replacing Linezolid with OTB-658 in Anti-Tuberculosis Regimens in Murine Models
Haiting Liu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2023)
Superior Efficacy of a TBI-166, Bedaquiline, and Pyrazinam de Combination Regimen in a Murine Model of Tuberculosis
Yangming Ding et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)
Assessing Prolongation of the Corrected QT Interval with Bedaquiline and Delamanid Coadministration to Predict the Cardiac Safety of Simplified Dosing Regimens
Lenaig Tanneau et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)
An Improved Method for Cytochrome P450 Reaction Phenotyping Using a Sequential Qualitative-Then-Quantitative Approach
Angela C. Doran et al.
DRUG METABOLISM AND DISPOSITION (2022)
Herb-Drug Interaction Between Xiyanping Injection and Lopinavir/Ritonavir, Two Agents Used in COVID-19 Pharmacotherapy
Linhu Ye et al.
FRONTIERS IN PHARMACOLOGY (2021)
Influence of Inflammation on Cytochromes P450 Activity in Adults: A Systematic Review of the Literature
Camille Lenoir et al.
FRONTIERS IN PHARMACOLOGY (2021)
Relationship between Plasma and Intracellular Concentrations of Bedaquiline and Its M2 Metabolite in South African Patients with Rifampin-Resistant Tuberculosis
Precious Ngwalero et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
2020 FDA Drug-drug Interaction Guidance: A Comparison Analysis and Action Plan by Pharmaceutical Industrial Scientists
Sirimas Sudsakorn et al.
CURRENT DRUG METABOLISM (2020)
In Vitro and In Vivo Activities of the Riminophenazine TBI-166 against Mycobacterium tuberculosis
Jian Xu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Atipamezole is a promising non-discriminative inhibitor against pan-CYP450 including diclofenac 4′-hydroxylation: A comparison with ABT for drug ADME optimization and mechanism study
Zheng Li et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Identifying Regimens Containing TBI-166, a New Drug Candidate against Mycobacterium tuberculosis In Vitro and In Vivo
Ye Zhang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Bedaquiline and delamanid in the treatment of multidrug-resistant tuberculosis: Promising but challenging
Yang Li et al.
DRUG DEVELOPMENT RESEARCH (2019)
Human hepatocytes and cytochrome P450-selective inhibitors predict variability in human drug exposure more accurately than human recombinant P450s
Bo Lindmark et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Evaluation of Clinical Drug Interaction Potential of Clofazimine Using Static and Dynamic Modeling Approaches
Ramachandra Sangana et al.
DRUG METABOLISM AND DISPOSITION (2018)
CYP3A4 inducer and inhibitor strongly affect the pharmacokinetics of triptolide and its derivative in rats
Ye Xu et al.
ACTA PHARMACOLOGICA SINICA (2018)
Confirming model-predicted pharmacokinetic interactions between bedaquiline and lopinavir/ritonavir or nevirapine in patients with HIV and drug-resistant tuberculosis
Margreke J. E. Brill et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Dose- and Time-dependency of the Toxicity and Pharmacokinetic Profiles of Bedaquiline and Its N-desmethyl Metabolite in Dogs
Ilham Smyej et al.
TOXICOLOGIC PATHOLOGY (2017)
Drug-drug interactions between bedaquiline and the antiretrovirals lopinavir/ritonavir and nevirapine in HIV-infected patients with drug-resistant TB
Mishal Pandie et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Comparative Study of the Effects of Antituberculosis Drugs and Antiretroviral Drugs on Cytochrome P450 3A4 and P-Glycoprotein
Yasuhiro Horita et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Bedaquiline: a review of human pharmacokinetics and drug-drug interactions
R. P. G. van Heeswijk et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Expression of Hepatic Drug-Metabolizing Cytochrome P450 Enzymes and Their Intercorrelations: A Meta-Analysis
Brahim Achour et al.
DRUG METABOLISM AND DISPOSITION (2014)
Bedaquiline Metabolism: Enzymes and Novel Metabolites
Ke Liu et al.
DRUG METABOLISM AND DISPOSITION (2014)
Model-Based Estimates of the Effects of Efavirenz on Bedaquiline Pharmacokinetics and Suggested Dose Adjustments for Patients Coinfected with HIV and Tuberculosis
Elin M. Svensson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Clofazimine Analogs with Efficacy against Experimental Tuberculosis and Reduced Potential for Accumulation
Yu Lu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Utility of Intersystem Extrapolation Factors in Early Reaction Phenotyping and the Quantitative Extrapolation of Human Liver Microsomal Intrinsic Clearance Using Recombinant Cytochromes P450
Yuan Chen et al.
DRUG METABOLISM AND DISPOSITION (2011)
Optimizing classification of drug-drug interaction potential for CYP450 isoenzyme inhibition assays in early drug discovery
Ben-Fillippo Krippendorff et al.
JOURNAL OF BIOMOLECULAR SCREENING (2007)